Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cementos Bio-Bio's Total Stockholders Equity for the quarter that ended in Dec. 2025 was CLP288,150 Mil. Cementos Bio-Bio's Total Assets for the quarter that ended in Dec. 2025 was CLP528,134 Mil.
Therefore, Cementos Bio-Bio's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.55.
The historical rank and industry rank for Cementos Bio-Bio's Equity-to-Asset or its related term are showing as below:
XSGO:CEMENTOS'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44 Med: 0.52 Max: 0.55
Current: 0.55
During the past 13 years, the highest Equity to Asset Ratio of Cementos Bio-Bio was 0.55. The lowest was 0.44. And the median was 0.52.
XSGO:CEMENTOS's Equity-to-Asset is not ranked
in the Building Materials industry.
Industry Median: 0.55
vs XSGO:CEMENTOS: 0.55
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Cementos Bio-Bio Equity-to-Asset Related Terms
Cementos Bio-Bio Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Cementos Bio-Bio's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSGO:CEMENTOS vs CRH, VMC, MLM: Equity-to-Asset Comparison
For the Building Materials subindustry, Cementos Bio-Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cementos Bio-Bio Equity-to-Asset vs Building Materials Industry
For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Cementos Bio-Bio's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Cementos Bio-Bio's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cementos Bio-Bio (XSGO:CEMENTOS) has a Equity-to-Asset of 0.55 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cementos Bio-Bio and its competitors. This is near median its historical median of 0.52. Over the past decade, Cementos Bio-Bio's Equity-to-Asset has ranged from 0.44 to 0.55.
Is Cementos Bio-Bio's Equity-to-Asset too high?
Cementos Bio-Bio's current Equity-to-Asset of 0.55 is near median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 0.55. The Building Materials industry median Equity-to-Asset is 0.55. Cementos Bio-Bio's value of 0.55 is 0% at this industry median. Overall, Cementos Bio-Bio has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's Equity-to-Asset compare to CRH and VMC?
Cementos Bio-Bio's Equity-to-Asset of 0.55 can be compared against companies in the Building Materials industry. The industry median Equity-to-Asset is 0.55. Cementos Bio-Bio's value of 0.55 is 0% at this benchmark. Historically, Cementos Bio-Bio's own Equity-to-Asset has ranged from 0.44 to 0.55 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 0.55, Cementos Bio-Bio has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Building Materials company?
The median Equity-to-Asset among Building Materials companies is 0.55, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cementos Bio-Bio's current Equity-to-Asset of 0.55 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cementos Bio-Bio and its competitors. For the Building Materials industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cementos Bio-Bio's current Equity-to-Asset is 0.55, which is near median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Cementos Bio-Bio (XSGO:CEMENTOS) has a current Equity-to-Asset of 0.55. The stock's GF Value™ is CLP742.22, compared to a current price of CLP1,730.00 — trading 133.1% above its estimated fair value. The current Equity-to-Asset is 0.55, which is near median its 10-year median of 0.52 and 0% at the Building Materials industry median of 0.55. Cementos Bio-Bio's overall GF Score™ is 34/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current Equity-to-Asset is 0.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?
Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued.
The current stock price of CLP1,730.00 is trading 133.1% above its estimated GF Value™ of CLP742.22.
Key valuation signals for XSGO:CEMENTOS:
Equity-to-Asset: 0.55 (near median its 10-year median of 0.52)
GF Value™: CLP742.22 vs. price of CLP1,730.00 (133.1% above fair value)
Industry Position: 0% at the Building Materials median
No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:CEMENTOS has been successfully added to your 
